4//SEC Filing
KING RICHARD 4
Accession 0001209191-18-014826
CIK 0001328143other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 12:14 PM ET
Size
5.2 KB
Accession
0001209191-18-014826
Insider Transaction Report
Form 4
KING RICHARD
Chief Operating Officer
Transactions
- Award
Common Stock
2018-02-28$25.07/sh+10,000$250,700→ 39,661 total
Footnotes (2)
- [F1]The shares were purchased at prices ranging from $25.05 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 1,536 shares purchased on 11/30/17 through the issuer's employee stock purchase plan.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001013702
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 12:14 PM ET
- Size
- 5.2 KB